Professor Chris Rowe talks about promising new Alzheimer's drug Lecanemab

Professor Chris Rowe talks about promising new Alzheimer's drug LecanemabПодробнее

New study on drug 'Lecanemab' shows promise for Alzheimer's disease treatmentПодробнее

Lecanemab: A Potential New Drug For Alzheimer's diseaseПодробнее

Hope and anxiety surround new Alzheimer’s drug lecanemabПодробнее

Alzheimer’s drug lecanemab receives accelerated approval from FDAПодробнее

Alzheimer's drug lecanemab can slow cognitive decline, study showsПодробнее

How soon could lecanemab be prescribed to treat Alzheimer's?Подробнее

New Alzheimer's drug shows promise in early results of studyПодробнее

Alzheimer's drug lecanemab: "It's a major breakthrough"Подробнее

FDA approvals new Alzheimer's drug.Подробнее

Updates in pharmacological treatment of Alzheimer’s disease: lecanemab, donanemab and gantenerumabПодробнее

Lecanemab path to approvalПодробнее

Lecanemab - a breakthrough in treating Alzheimer´s disease?Подробнее

New Alzheimer's drug shows promise in slowing diseaseПодробнее

New drug could slow cognitive decline of Alzheimer's diseaseПодробнее

Lecanemab for the treatment of early Alzheimer’s disease: the story so farПодробнее

Professor Jonathan Schott on the exciting developments of Alzheimer's drugs lecanemab and donanemabПодробнее

Experimental drug Lecanemab may be a landmark breakthrough in battle against Alzheimer'sПодробнее

Alzheimer's drug lecanemab approved in the USПодробнее

New Alzheimer's Medication TreatmentПодробнее